Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN16586164Phase 4Completed
Phase 4, randomised, open-label trial of plasma-lyte in hyponatraemia (2 arms), sponsored by Great Ormond Street Hospital. Primary endpoint: Acute hyponatraemia in first 72 hours post-transplant. Started Feb 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN16586164.